Formulation and evaluation of effervescent tablets: a review
Oral dosage forms are the most popular way of taking medication, despite having some disadvantages compared with other methods like risk of slow absorption of the medicament, which can be overcome by administering the drug in liquid form, therefore, possibly allowing the use of a lower dosage. However, instability of many drugs in liquid dosage form limits its use. Effervescent technique can be used as alternate to develop a dosage form which can accelerate drug disintegration and dissolution, is usually applied in quick release preparations. Along with the development of new pharmaceutical technique, effervescent tablet are more and more extensively to adjust the behaviour of drug release, such as in sustained and controlled release preparations, pulsatile drug delivery systems, and so on. This review demonstrated the new applying of effervescent technique in effervescent tablets.
Keywords: Effervescent Tablet, Sustained release, Floating Delivery System
2. Singh BN, Kim KH, Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention, Journal of Controlled release, 2000; (63):235–59.
3. Deepali DW, Madhav MS, Jain DS, Gastroretentive Floating Microspheres: A Review, International Journal Of Pharmacy &Technology, 2011; 3(4):1783-1799.
4. Singh LP, Rajesh KS, Umalkar DG, Chauhan VK, Rana VK, Vasava KS, Floating Effervescent Tablet : A Review, Journal of pharmaceutical and biomedical sciences, 2011; 5(11):1-6.
5. Agyilirah GA, Green M, DuCret R, Banker GS, Evaluation of the gastric retention properties of a cross-linked polymer coated tablet versus those of a non-disintegrating tablet, International Journal of Pharmaceutics, 1991; 75: 241–47.
6. Mohrle, R., Liberman, L,Schwartz L, Pharmaceutical Dosage Form, Vol. 1, Marcel Decker Inc., New York, 2005; 285- 292.
7. Lachman L, Liberman HA, Kanig JL. The theory and practice of industrial pharmacy. 3rd ed. Philadelphia: lea and febiger; 1986.
8. Swarbrick J, Boylan JC. Encyclopaedia of pharmaceutical technology. New York: Marcel Dekker; 2002
9. Harald S, Effervescent Dosage, Pharmaceutical Technology Europe, 2003; 15(4): 25–28.
10. Srinath KR, “Formulation and Evaluation of Effervescent tablets of Paracetamol”, International Journal of Pharmaceutical Research & Development, 2011; 3(3):76- 104.
11. Indian Pharmacopoeia, Government of India Ministry of Health and Family Welfare. Delhi: Controller of Publications 1996; 2: 35, 448, 554.
12. Howard CA, Lloyd A, Nocholas and Popovich, “Effervescent granules”8th edition “Pharmaceutical Dosage From and Drug Delivery” International Student Edition.-2000, 172-178.
13. Dixit N, Maurya SD, Sagar BPS, Sustained release drug delivery system, Indian Journal of Research in Pharmacy and Biotechnology, 2013; 1(3): 305-310.
14. Shimodaira S, Quality Verification of Dendritic Cell-Based Cancer Vaccine. Pharm Anal Acta, 2016; 7:467.
15. Hassali MA, Role of Pharmacists in Health Based Non-Governmental Organizations NGO: Prospects and Future Directions, Pharm Anal Acta. 2016; 7:467.
16. Vergeire DG, Usefulness of Cost Effectiveness: Evidence versus Applicability. Pharm Anal Acta, 2016; 7:456.
17. Wang C, Application of In Vitro Models in Developmental Neurotoxicity and Pharmaceutics Research, Journal of Molecular Pharmaceutics & Organic Process Research, 2015;3:122-128..
18. Lyubchenko YL, Nanoimaging for Molecular Pharmaceutics of Alzheimer’s and other Neurodegenerative Disorders, Journal of Molecular Pharmaceutics & Organic Process Research, 2013;1:107-111..
19. Skalkz BN, Note on the “Molecular Pharmaceutics and Organic Process”. Journal of Molecular Pharmaceutics & Organic Process Research, 2013; 1:104-110.
20. Foldvari M, Nanopharmaceutics Innovations in Gene Therapy: Moving Towards Non-Viral and Non-Invasive Delivery Methods. J Nanomedine Biotherapeutic Discovery. 2014; 4:135.
21. Maurya SD, Rawal RK, Jha S, Chauhan PS, Kumar A, Drug Loaded Beads: Current Status, American Journal of Pharm Tech Research, 2013; 3 (1): 331-337.
22. Sallam A, Bioequivalence of Two Oral Formulations of Modafinil Tablets in Healthy Male Subjects under Fed and Fasting Conditions. Journal of Bioequivalence Availability. 2015; 7:63-67.
23. Agatonovic KS, Biorelevant Dissolution Studies of Pioglitazone HCL Immediate Release Tablets and the Determination of an In Vitro In Vivo Correlation, Journal of Bioequivalence Availability, 2015; 7:086-089.
24. Abdul AS, Formulation, Evaluation and Mathematical Modeling of Clopidogrel Bisulphate & Aspirin Immediate Release Bilayer Tablets, Pharmaceutca Anal Acta, 2012;3:194.
25. Biswas D and Halquist M, Using Biorelevant in Vitro Models Testing to Characterize Release of Non Oral Dosage Forms as another Tool for Safety. Journal of Pharmacovigilance, 2016; 4:153-160.
26. Bhattacharjee J. Mass Drugs Administration in India - A Failure Story. Epidemiology, Sunnyvale, 2016; 6:252.
27. Swain S and Beg S. Emergence in the Lipid-Based Nanostructured Systems for Optimizing Oral Delivery of Drugs. Pharmaceutical Regulatory Affairs, 2016; 5:157-163.
28. Kokardekar RR, Development and Evaluation of Sustained Release Microspheres of Glibenclamide by Emulsion Solvent Evaporation Method. Clinical Pharmacology and Biopharmaceutics, 2014; 3:127.
29. Cho SK. The Synergistic Effects of Pioglitazone on the Glucose-Lowering Action of Metformin in Relation to OCT1 and Gluts m-RNA Expression in Healthy Volunteer. Clinical Pharmacology and Biopharmaceutics, 2015; 3:129.
30. Ehrenpreis ED, A Survey of Lawsuits Filed for the Complaint of Tardive Dyskinesia Following Treatment with Metoclopramide. Clinical Pharmacology and Biopharmaceutics, 2015; 4:131.
31. Patil JS, Hydrogel System: An Approach for Drug Delivery Modulation, Advance Pharmacoepidemiology and Drug Safety, 2015; 4:135.
32. Patil JS, Novel Tubercular Therapeutic Agents: Need of the Day, Advance Pharmacoepidemiology and Drug Safety, 2015; 4:137.
33. Obara T, Prevalence, Determinants, and Reasons for the Non-Reporting of Adverse Drug Reactions by Pharmacists in the Miyagi and Hokkaido Regions of Japan, Advance Pharmacoepidemiology and Drug Safety, 2015; 4:191.
34. Teoh BC, et al. Perceptions of Doctors and Pharmacists towards Medication Error Reporting and Prevention in Kedah, Malaysia: A Rasch Model Analysis. AdvPharmacoepidemiol Drug Saf. 2015; 4:192.
35. United States Pharmacopeia 31/National Formulary 26. Rockville MD USA: United States Pharmacopeial Convention; 2008.
36. Yanze FM, Duru C, Jacob M, A process to produce effervescent tablets: Fluidized bed dryer melt granulation. Drug Development & Industrial Pharmacy, 2000; 26(11):1167-76.
37. Simona B, Tanja R, Using different experimental designs in drug excipient Compatibility Studies during the Pre-formulation development of a stable solid dosage formulation, Acta Chimica Slovenica, 2010; 57:895-903.
38. Larry LA and Stephan WH, Pharmaceutical Dosage Form: Tablets 3rd edition Vol. 1: 465.
39. Aboud HM, Elbary A, Ali AA, Enhanced dissolution of meloxicam from orodispersible tablets prepared by different methods, Bulletin of Faculty of Pharmacy, Cairo University, 2012;50:89–97.
40. Ahmed I, Aboul-Einien M, In vitro and in vivo evaluation of a fast disintegrating lyophilized dry emulsion tablet containing griseofulvin, European Journal of Pharmaceutical Sciences. 2007; 32:58–68.
41. Dhakar RC, Maurya SD, Dangi G, Kumar G , Gupta M, Kiroriwal S, Buccal Adhesive Dosage Forms As A NISDD: A Pharmaceutical Review, Research Pharmaceutica, 2010; 1(1): 46-59.
42. Aly AM, Amro BI, Hajji FD, Preparation and Evaluation of Rapidly Disintegrating Glimepiride Tablets. International Journal of Pharmaceutical Sciences and Nanotechnology, 2011; 3(4):1220-1229.
43. Ashish P, Harsoliya MS, Pathan JK, Shruti S, A Review- Formulation of Mouth Dissolving tablet, International Journal of Pharmaceutical and Clinical Science, 2011; 1(1):1-8.
44. Sandhyarani G, Kumar KP, Formulation and evaluation of fast dissolving Tablet of imidapril, Indian Journal of Pharmaceutical Science& Research, 2017;4(3):147-150.
45. Dhakar RC, Maurya SD, Gupta AK, Siddiqui AW, Interpenetrating polymeric network hydrogel for stomach-specific drug delivery of clarithromycin: Preparation and evaluation, Asian Journal of Pharmaceutics, 2010; 4(4): 184-189.
46. Dhakar RC, Maurya SD, Aggarawal S, Kumar G, Tilak VK, Design and evaluation of SRM microspheres of Metformin hydrochloride, Pharmacie Globale(IJCP), 2010; 1(07):1-6.
47. Dhakar RC, Maurya SD, Sagar BPS, Prajapati SK, Jain CP, Variables influencing the drug entrapment efficiency of microspheres: a pharmaceutical review, Der Pharmacia Lettre, 2010; 2(5): 102-116.
48. Sastry SV, Nyshdham JR, Fix JA, Recent technological advances in oral drug delivery: A review. Pharmaceutical Science and Technology Today, 2000; 1(3): 38-45.
49. Maurya SD, Tilak VK, Dhakar RC, Verma KK, Soni U, Gupta, Preparation and evaluation of floating tablet of famotidine through solid dispersion, International Journal of Current Research and Review, 2011; (2)1: 21-30.
50. Thoke SB, Sharma Y., Rawat S, Nangude, SFormulation development & evaluation of effervescent tablet of Alendronate sodium with vitamin D3, Journal of Drug Delivery & Therapeutics; 2013; 3(5):65-74.
51. Abolfazl A, Formulation, Characterization and Physicochemical Evaluation of Ranitidine Effervescent Tablets, Advanced Pharmaceutical Bulletin, 2013; 3(2): 315-322.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).